Monsanto can execute another reinvention, says Citigroup Citigroup believes Monsanto is reinventing itself like it did when Roundup went off patent in the late 1990's by using the cash flow from the seeds business to get into new growth areas. Citi thinks management can execute the transition but admits the stock may be range-bound over the near-term. The firm keeps a Buy rating on Monsanto with a $146 price target.
GMO seed makers limit launches as China slow on approvals, Reuters says Seed companies like Syngenta (SYT), Dow AgroSciences (DOW) and Bayer (BAYRY) are altering their plans for new product launches as China has taken longer than usual to approve new GMO crops, says Reuters. Grain traders Cargill and Archer Daniels Midland (ADM) have already sued Syngenta, claiming the seed company misrepresented how long it would take to win Chinese approval for the seeds, added Reuters. Monsanto (MON) is another company in the seed business. Reference Link